American Riviera
You are here:  Home  >  Central Coast Health Watch  >  Current Article

FDA gives big win to Amgen in biosimilars race

By   /   Friday, September 30th, 2016  /   Comments Off on FDA gives big win to Amgen in biosimilars race

    Print       Email
Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Amgen is officially in the biosimilar game. The Food and Drug Administration approved the Thousand Oaks-biotech giant’s Humira biosimilar Sept. 23, making it the first Amgen biosimilar approved for sale anywhere in the world. The approval could be a windfall for the…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Cities move toward permanent outdoor dining

Read More →